Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 12660892)

Published in Horm Metab Res on March 27, 2003

Authors

C Bélanger1, V Luu-The, P Dupont, A Tchernof

Author Affiliations

1: Molecular Endocrinology and Oncology Research Center, Quebec, Canada.

Associated clinical trials:

Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL) (EIFFEL) | NCT01745471

Articles citing this

Gender differences in insulin resistance, body composition, and energy balance. Gend Med (2009) 3.19

Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol (2007) 1.79

Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol (2008) 1.66

Sex dimorphism and depot differences in adipose tissue function. Biochim Biophys Acta (2013) 1.10

Androgens and adipose tissue in males: a complex and reciprocal interplay. Int J Endocrinol (2011) 0.89

De novo synthesis of steroids and oxysterols in adipocytes. J Biol Chem (2013) 0.87

Estrogen signaling in metabolic inflammation. Mediators Inflamm (2014) 0.85

Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial. Med Sci Sports Exerc (2008) 0.85

The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83

Influence of androgens on circulating adiponectin in male and female rodents. PLoS One (2012) 0.82

Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome. Diabetes (2014) 0.81

Obesity and cancer, a case for insulin signaling. Cell Death Dis (2015) 0.79

Influence of ovarian and non-ovarian estrogens on weight gain in response to disruption of sweet taste--calorie relations in female rats. Horm Behav (2012) 0.79

Body Size, Metabolic Factors, and Risk of Endometrial Cancer in Black Women. Am J Epidemiol (2016) 0.78

Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome. World J Diabetes (2016) 0.77

Intramuscular sex steroid hormones are associated with skeletal muscle strength and power in women with different hormonal status. Aging Cell (2015) 0.77

The Relationship Between Greater Prepubertal Adiposity, Subsequent Age of Maturation, and Bone Strength During Adolescence. J Bone Miner Res (2016) 0.77

The relationship between endogenous androgens and body fat distribution in early and late postmenopausal women. PLoS One (2013) 0.76

Baseline estradiol concentration in community-dwelling Japanese American men is not associated with intra-abdominal fat accumulation over 10 years. Obes Res Clin Pract (2015) 0.75

Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization. Drug Des Devel Ther (2015) 0.75

Supplementary health benefits of linoleic Acid by improvement of vaginal cornification of ovariectomized rats. Adv Pharm Bull (2013) 0.75

Role of sex hormones in the modulation of cholangiocyte function. World J Gastrointest Pathophysiol (2010) 0.75

Female adipocyte androgen synthesis and the effects of insulin. Mol Genet Metab Rep (2014) 0.75

Association Between Obesity and Migraine in Women. Curr Pain Headache Rep (2017) 0.75

Articles by these authors

(truncated to the top 100)

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation (1997) 4.81

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation (2000) 3.78

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab (2001) 3.11

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer (2003) 2.97

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol (2002) 2.86

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol (2000) 2.77

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol (2001) 2.33

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA (1998) 2.28

An iterative maximum-likelihood polychromatic algorithm for CT. IEEE Trans Med Imaging (2001) 2.09

Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord (2000) 2.08

Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Mol Endocrinol (1991) 2.07

Collagenous colitis: an unrecognised entity. Gut (1980) 1.90

Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int (2006) 1.89

The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology. Steroids (1997) 1.76

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers. Ann Oncol (2012) 1.61

Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care (2001) 1.58

DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol (2001) 1.57

Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care (1999) 1.57

Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol (2000) 1.54

Iterative reconstruction for helical CT: a simulation study. Phys Med Biol (1998) 1.53

Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) (2007) 1.49

Is dehydroepiandrosterone a hormone? J Endocrinol (2005) 1.46

Different regional brain activity during physiological gastric distension compared to balloon distension: a H2 15O-PET study. Neurogastroenterol Motil (2010) 1.45

Simultaneous maximum a posteriori reconstruction of attenuation and activity distributions from emission sinograms. IEEE Trans Med Imaging (1999) 1.42

Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Endocrinology (1999) 1.42

Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol Rev (1999) 1.40

Simple design for rapid self-injection ictal SPET during aura. Eur J Nucl Med (1999) 1.40

Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab (2000) 1.37

DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids (1998) 1.35

Scaling laws in aeolian sand transport. Phys Rev Lett (2011) 1.31

Propriospinal myoclonus revisited: Clinical, neurophysiologic, and neuroradiologic findings. Neurology (2009) 1.30

Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry. Br J Cancer (2004) 1.30

SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain (2003) 1.25

Molecular cloning of human type 3 3 alpha-hydroxysteroid dehydrogenase that differs from 20 alpha-hydroxysteroid dehydrogenase by seven amino acids. Biochem Biophys Res Commun (1996) 1.25

Menopause-related changes in body fat distribution. Ann N Y Acad Sci (2000) 1.21

Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. J Clin Oncol (1999) 1.19

A motion area in human visual cortex. Proc Natl Acad Sci U S A (1995) 1.17

Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Steroid Biochem Mol Biol (1999) 1.16

Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hippocampal sclerosis. Neuroimage (2006) 1.15

Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells. J Biol Chem (1990) 1.15

Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology (1999) 1.14

Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. DNA Cell Biol (1997) 1.13

17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol (1999) 1.11

Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J Steroid Biochem Mol Biol (1992) 1.11

Traversing the menopause: changes in energy expenditure and body composition. Coron Artery Dis (1998) 1.10

Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol (1998) 1.06

Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol (2000) 1.06

Particle velocity distribution in saltation transport. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 1.05

Attention to one or two features in left or right visual field: a positron emission tomography study. J Neurosci (1997) 1.05

Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? Br J Haematol (2001) 1.05

Effects of estradiol and progesterone on body composition, protein synthesis, and lipoprotein lipase in rats. Am J Physiol Endocrinol Metab (2001) 1.03

Respiratory fitness, free living physical activity, and cardiovascular disease risk in older individuals: a doubly labeled water study. J Clin Endocrinol Metab (2000) 1.02

Structure of the human 3alpha-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25-A resolution. J Biol Chem (2001) 1.01

Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys (1998) 1.01

Human brain regions involved in heading estimation. J Neurosci (2001) 1.00

[Carrington's disease without eosinophils in the bronchial lavage]. Rev Mal Respir (2007) 1.00

Characterization of a human 20alpha-hydroxysteroid dehydrogenase. J Mol Endocrinol (2000) 1.00

Molecular biology and genetics of the 3 beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. J Endocrinol (1996) 0.99

Oestrogenic regulation of pro-opiomelanocortin, neuropeptide Y and corticotrophin-releasing hormone mRNAs in mouse hypothalamus. J Neuroendocrinol (2007) 0.97

Lipid metabolism in the elderly. Eur J Clin Nutr (2000) 0.97

Size quantification of liver metastases in patients undergoing cancer treatment: reproducibility of one-, two-, and three-dimensional measurements determined with spiral CT. Radiology (1997) 0.96

18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact. Melanoma Res (2002) 0.96

Structure of human type II 5 alpha-reductase gene. Endocrinology (1992) 0.96

Intracrinology and the skin. Horm Res (2000) 0.96

Maximum-likelihood expectation-maximization reconstruction of sinograms with arbitrary noise distribution using NEC-transformations. IEEE Trans Med Imaging (2001) 0.95

Science behind total androgen blockade: from gene to combination therapy. Clin Invest Med (1993) 0.95

Resting brain perfusion in social anxiety disorder: a voxel-wise whole brain comparison with healthy control subjects. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.94

EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. J Steroid Biochem Mol Biol (1999) 0.94

Molecular characterization of a first human 3(alpha-->beta)-hydroxysteroid epimerase. J Biol Chem (2000) 0.92

Canonical decomposition of ictal scalp EEG reliably detects the seizure onset zone. Neuroimage (2007) 0.92

Immunoelectron microscopic localization of 3beta-hydroxysteroid dehydrogenase and type 5 17beta-hydroxysteroid dehydrogenase in the human prostate and mammary gland. J Mol Endocrinol (2001) 0.92

The influence of stimulus location on the brain activation pattern in detection and orientation discrimination. A PET study of visual attention. Brain (1996) 0.91

Immunoelectron microscopic localization of three key steroidogenic enzymes (cytochrome P450(scc), 3 beta-hydroxysteroid dehydrogenase and cytochrome P450(c17)) in rat adrenal cortex and gonads. J Endocrinol (2001) 0.90

Cortical deactivations during gastric fundus distension in health: visceral pain-specific response or attenuation of 'default mode' brain function? A H2 15O-PET study. Neurogastroenterol Motil (2008) 0.90

["Intracrinology". Autonomy and freedom of peripheral tissues]. Ann Endocrinol (Paris) (1995) 0.90

Structure, regulation and role of 3 beta-hydroxysteroid dehydrogenase, 17 beta-hydroxysteroid dehydrogenase and aromatase enzymes in the formation of sex steroids in classical and peripheral intracrine tissues. Baillieres Clin Endocrinol Metab (1994) 0.89

A study of the liver-heart artifact in emission tomography. J Nucl Med (1995) 0.88

De novo cryptogenic refractory multifocal febrile status epilepticus in the young adult: a review of six cases. Acta Neurol Belg (2003) 0.88

Motor learning-induced changes in functional brain connectivity as revealed by means of graph-theoretical network analysis. Neuroimage (2012) 0.88

Structure and tissue-specific expression of 3 beta-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase genes in human and rat classical and peripheral steroidogenic tissues. J Steroid Biochem Mol Biol (1992) 0.88

Crystallization and preliminary crystallographic results of apo and complex forms of human dehydroepiandrosterone sulfotransferase. Acta Crystallogr D Biol Crystallogr (2001) 0.88

Characterization, expression, and immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin. J Invest Dermatol (1992) 0.88

Conversion of pregnenolone to DHEA by human 17alpha-hydroxylase/17, 20-lyase (P450c17). Evidence that DHEA is produced from the released intermediate, 17alpha-hydroxypregnenolone. Eur J Biochem (2000) 0.88

Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study. J Steroid Biochem Mol Biol (2006) 0.88

Localization and glucocorticoid regulation of 11beta-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain. Neuroscience (2007) 0.88

Maintaining and shifting attention within left or right hemifield. Cereb Cortex (2000) 0.88

Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women. Int J Obes (Lond) (2011) 0.88

Characterization of rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase cDNAs and differential tissue-specific expression of the corresponding mRNAs in steroidogenic and peripheral tissues. J Biol Chem (1991) 0.87

The neural substrate of orientation working memory. J Cogn Neurosci (2001) 0.87

Subunit identity of the dimeric 17 beta-hydroxysteroid dehydrogenase from human placenta. J Biol Chem (1992) 0.87

Immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase in the brain of the African lungfish Protopterus annectens. J Comp Neurol (2001) 0.87

The Role of CT-Based Attenuation Correction and Collimator Blurring Correction in Striatal Spect Quantification. Int J Mol Imaging (2011) 0.86

Immunocytochemical localization of type I 17 beta-hydroxysteroid dehydrogenase in the rat brain. Brain Res (1995) 0.85

Plasma adrenal, gonadal, and conjugated steroids before and after long-term overfeeding in identical twins. J Clin Endocrinol Metab (1998) 0.85

The octadecaneuropeptide ODN stimulates neurosteroid biosynthesis through activation of central-type benzodiazepine receptors. J Neurochem (2001) 0.85

Post-heparin lipolytic enzyme activities, sex hormones and sex hormone-binding globulin (SHBG) in men and women: The HERITAGE Family Study. Atherosclerosis (2003) 0.85

Immunocytochemical localization of 5 alpha-reductase in rat brain. Mol Cell Neurosci (1994) 0.85

Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters. J Steroid Biochem Mol Biol (2008) 0.85

Localization of type 5 17beta-hydroxysteroid dehydrogenase mRNA in mouse tissues as studied by in situ hybridization. Cell Tissue Res (2005) 0.84

Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Trends Endocrinol Metab (2000) 0.84